SDI Launches Azma.com to Empower Consumers to Make Informed Decisions about Asthma Treatment and Medications

SDI, the leader in innovative healthcare analytics, has announced the launch of Azma.com to help the increasing number of consumers impacted by asthmatic conditions. Azma.com addresses the nation’s growing incidence of asthma with four-day forecasts for all U.S. ZIP codes, disease-specific educational information, opt-in email alerts and more, and is the newest addition to SDI’s suite of consumer health alert websites that includes the number one U.S. consumer allergy site, Pollen.com.

“According to the Centers for Disease Control and Prevention (CDC), more than 22 million Americans suffer from asthma, a number that has continued to increase over the past three decades,” said SDI President Andrew Kress. “Azma.com provides an effective, 24/7 communication vehicle for valuable asthma news and information, as well as timely email alerts that enable asthma sufferers to successfully manage their condition and make better-informed medication decisions.”

Azma.com allows consumers to efficiently manage their asthmatic conditions with four-day asthma forecasts for all U.S. ZIP codes, opt-in Asthma Alert emails and an air quality index. Additionally, the free online resource provides access to current asthma and allergy-specific news, as well as two years of archived allergy news. The Azma.com information is also available via a network of affiliated health- and weather-related national websites.

Added Kress, “We have received a steady stream of requests from the users of Pollen.com to develop an asthma-specific resource that incorporates many of their favorite Pollen.com features. We listened and created Azma.com to deliver valuable medical information and discounts to consumers who struggle to control their asthma.”

About SDI

Since 1982, SDI has been delivering the most innovative healthcare data products and analytic services on the market to the pharmaceutical, biotech, healthcare, medical device, and consumer packaged goods industries. SDI is a leading provider of de-identified patient-level data, as well as real-time localized disease and treatment surveillance and modeling data. SDI takes a consultative approach to designing the best analyses for its clients, combined with expert study execution and analytical expertise to produce superior insights. Its current roster of client companies in the pharmaceutical/biotech sector includes all of the top 20 firms. For more information, visit www.survdata.com or call 610.834.0800.

Tags

SDI, Azma.com, Asthma Treatment, Medication, asthma forecast, asthma sufferers, healthcare analytics, Azma, asthmatic conditions, asthma, four-day forecasts, health alert, allergy site, Pollen.com, Centers for Disease Control and Prevention, CDC, Andrew Kress, health, wellness, seniors, teens, parents, women, physician, medical, marketing, data, analytic, pharmaceutical, biotech, healthcare, medical device, consumer packaged goods, de-identified, patient-level data, disease, treatment, surveillance, modeling data